培菲康与思密达交替应用预防小儿腹泻病临床效果评价

2016-09-10王乐男张峥买春芳河南新乡医学院第三附属医院儿科河南新乡453003

系统医学 2016年7期

王乐男，张峥，买春芳河南新乡医学院第三附属医院儿科，河南新乡　453003

王乐男，张峥，买春芳
河南新乡医学院第三附属医院儿科，河南新乡453003

目的评价培菲康与思密达交替应用预防小儿腹泻病的临床效果。方法选取2013年4月—2015年1月期间该院儿科收治的87例腹泻病患儿进行研究，将其随机分为对照组（n=40）和观察组（n=47），对照组予以思密达治疗，观察组予以培菲康与思密达交替治疗，对比两组患儿治疗的临床效果。结果对照组的总有效率为83%，观察组的总有效率为96%，对照组患儿退热、止泻、大便正常恢复的时间均长于观察组，组间比较，P＜0.05。结论培菲康与思密达交替应用预防小儿腹泻病可以有效改善患儿的临床症状，提高治疗总有效率，具体推广价值。

培菲康；思密达；预防；小儿腹泻病；疗效

［Abstract］Objective To evaluate the clinical effect of Bifico combined with Smecta in the prevention of diarrhea in children.Methods From April 2013 to January 2015 were treated 87 cases of children with diarrhea were studied，which were randomly divided into control group（n=40）and observation group（n=47），the control group received Smecta treatment，observation group were given clinical efficacy Bifico smecta alternation therapy，in the comparison of clinical effect of the treatment of two groups of children.Results The total effective rate of the control group was 83%，the total effective rate of observation group was 96%，control group of children with fever，diarrhea，stool normal recovery time were significantly longer than that in the observation group，the difference between the two groups has statistical significance（P＜0.05）.Conclusion Bifico and Smecta alternate use of the prevention of diarrhea disease in children can effectively improve the patient's clinical symptoms，improve the total efficiency of the treatment，the specific promotion value.

［Key words］Bifico；Smecta；prevention；Infantile diarrhea；Curative effect

小儿腹泻是临床儿科常见的一种疾病，主要是由于感染引起肠内的酸性物质增加，导致肠内功能紊乱而发生腹泻［1］。腹泻病严重的阻碍小儿的生长发育，容易引起患儿的水电解质和酸碱电解质平衡紊乱，威胁患儿的健康安全［2-3］。如何有效的预防和降低腹泻的发病率是临床的焦点问题。此研究共选取2013年4月—2015年1月收治的87例腹泻患儿进行分组研究，探究培菲康与思密达交替应用预防小儿腹泻病临床效果，现将结果总结如下。